Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 1
2013 1
2014 4
2015 5
2016 7
2017 3
2018 6
2019 3
2020 2
2021 3
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Clinicogenomic characterization of prostate cancer liver metastases.
Alshalalfa M, Seldon C, Franco I, Vince R, Carmona R, Punnen S, Kaochar S, Dess R, Kishan A, Spratt DE, Sharma J, Dal Pra A, Pollack A, Abramowitz MC, Mahal BA. Alshalalfa M, et al. Among authors: carmona r. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):366-369. doi: 10.1038/s41391-021-00486-2. Epub 2022 Jan 12. Prostate Cancer Prostatic Dis. 2022. PMID: 35022600
SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.
Anstadt EJ, Carmona R, Berlin E, Yegya-Raman N, Venigalla S, Reddy V, Williams GR, Leibensperger MR, Wojcieszynski A, Baumann BC, Lee MK, Plastaras JP, Furth EE, Mell LK, Metz JM, Ben-Josef E. Anstadt EJ, et al. Among authors: carmona r. Cancer. 2024 Feb 1;130(3):476-484. doi: 10.1002/cncr.35058. Epub 2023 Oct 12. Cancer. 2024. PMID: 37823514
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer.
Andruska N, Michalski JM, Carmona R, Agabalogun T, Brenneman RJ, Gay HA, Fischer-Valuck BW, Baumann BC. Andruska N, et al. Among authors: carmona r. Brachytherapy. 2022 May-Jun;21(3):317-324. doi: 10.1016/j.brachy.2021.12.008. Epub 2022 Feb 3. Brachytherapy. 2022. PMID: 35123889 Free PMC article.
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
Andruska N, Agabalogun T, Fischer-Valuck BW, Brenneman RJ, Huang Y, Gay HA, Michalski JM, Carmona R, Baumann BC. Andruska N, et al. Among authors: carmona r. Brachytherapy. 2022 Sep-Oct;21(5):617-625. doi: 10.1016/j.brachy.2022.04.001. Epub 2022 May 28. Brachytherapy. 2022. PMID: 35641370 Free PMC article.
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Fischer-Valuck BW, Patel SA, Brenneman RJ, Christodouleas J, Sargos P, Kim E, Weiss A, Hershatter B, Rao YJ, Picus J, Roth B, Arora V, Carmona R, Reimers M, Zaghloul MS, Gay H, Michalski JM, Baumann BC. Fischer-Valuck BW, et al. Among authors: carmona r. Eur Urol Oncol. 2022 Apr;5(2):246-250. doi: 10.1016/j.euo.2022.02.001. Epub 2022 Mar 3. Eur Urol Oncol. 2022. PMID: 35249864 Free PMC article.
39 results